Pyroptosis and Inflammasome-Related Genes-NLRP3, NLRC4 and NLRP7 Polymorphisms Were Associated with Risk of Lung Cancer
Xin Jing,Yuhui Yun,Xiang Ji,Ende Yang,Pei Li
DOI: https://doi.org/10.2147/PGPM.S424326
2023-08-26
Pharmacogenomics and Personalized Medicine
Abstract:Xin Jing, &ast Yuhui Yun, &ast Xiang Ji, Ende Yang, Pei Li Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, 710038, People's Republic of China &astThese authors contributed equally to this work Correspondence: Pei Li; Ende Yang, Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, 710038, People's Republic of China, Email ; Background: Cancer development and tumor immune microenvironment remodeling are closely linked to pyroptosis and inflammasome activation. However, little information is available in single nucleotide polymorphisms (SNPs) in pyroptosis and inflammasome-related genes in patients with lung cancer. This study aims to evaluate the associations between pyroptosis-related gene ( NLRP3, NLRC4, and NLRP7 ) polymorphisms and the risk of lung cancer. Methods: The MassARRAY platform was used to genotype six SNPs of the NLRP3, NLRC4, and NLRP7 genes in 660 lung cancer cases and 660 controls. Results: Individuals with rs35829419-A, rs385076-C, and rs775882-T alleles exhibited a higher risk of lung cancer ( p < 0.01), while rs212704-T appears protective ( p = 0.006). The rs35829419-AA, rs385076-TC/CC, and rs775882-CT/TT genotypes were associated with various degrees of elevated risk of lung cancer ( p < 0.02), whereas rs212704-TT was associated with a reduced risk of the disease ( p =0.014). Genetic models analysis showed that rs35829419, rs385076, and rs775882 was associated with an increased risk of lung cancer, while rs212704 was related to a reduced risk in all three models ( p < 0.05). The four SNPs remained significant in smoker and nonsmoker subgroups ( p < 0.05). However, rs35829419 was correlated with risk of adenocarcinoma and small cell lung cancer, and rs212704 was only protective for squamous cell carcinoma. The rs385076 and rs775882 were associated with all three pathological types ( p < 0.01). Conclusion: Besides providing candidate markers for identification of high-risk populations and early prevention of the disease, our research also provided new insight into anti-tumor strategies targeting inflammasomes and pyroptosis. Keywords: lung cancer, single nucleotide polymorphisms, pyroptosis, inflammasome, case–control study Lung cancer is the most common malignant tumor in China, and its incidence and mortality rank first among all tumors. 1 Most patients with lung cancer were at an advanced stage by the time they noticed the symptoms of the disease. 2 Currently, lung cancer is treated mainly with surgical resection, radiotherapy, and chemotherapy, adjuvant to emerging molecular targeted therapy. 3 Although treatment has improved significantly, survival rates for most advanced cancer patients are still difficult to improve. According to statistics, only 15% of lung cancer patients survive 5 years after diagnosis. 4 Therefore, it is important to strengthen basic research in the field of lung cancer and find specific immune markers for improving the survival rate of the patients. Single nucleotide polymorphisms (SNPs) genotyping has the characteristics of being simple, quick, and efficient, making it a promising method for identification of high-risk populations and avoiding the onset of the disease to the maximum extent. Pyroptosis is a form of cell death closely related to inflammatory response. 5 It is manifested by the continuous expansion of cells until the integrity of the cell membrane is lost, followed by the release of cell contents and damage-associated molecular patterns, finally leading to a strong inflammatory immune response in the body. 6 In recent years, the importance of pyroptosis in various diseases and cancers has been gradually revealed, making it a research hotspot. 7 Pyroptosis is mediated by the gasdermin (GSDM) family, including the caspase-1 classical pathway and the caspase4/5/11 and caspase3/8 nonclassical pathways. 8 Inflammasomes are cytosolic polyprotein complexes that consist of NOD-like receptor (NLR), PYRIN domain, and HIN domain-containing family. It can mediate the lysis of a variety of inflammatory proteins such as GSDM family and are closely associated with pyroptosis. 9 A NLRP3 inflammasome activation could affect pyroptosis or hyperactivity, resulting in cascade immunity or inflammatory response and affecting anti-tumor immunity. 10 The formation and activation of NLRP3 inflammasomes has been linked to various tumors including colorectal, gastric, and lung cancers. 11 Moreover, activation of NLRC4 can recruit -Abstract Truncated-
pharmacology & pharmacy